News Focus
News Focus
icon url

cheynew

11/07/13 12:36 PM

#147664 RE: cjgaddy #147662

Thanks CJ. I'm glad they had the conference on their website for a reason.
icon url

Protector

11/07/13 12:42 PM

#147665 RE: cjgaddy #147662

cj I admire you :)

I have been browsing the SITC site for hours today, while waiting for my fill, to find SOMETHING on PPHM. No matter what, just something. Couldn't even find a boot plan with companies. Thought cheynew was kidding when she posted that but she clearly was not. Those guys at SITC run a show where you can't even see upfront online who is going to be there.

I have been looking for names as Brekken, Thorpe etc and didn't see them. I did 'find' on the pages for Peregrine and didn't find them.

Then two hours later you post the full enchilada (stolen term :)

Thanks! Really thanks.

PS : I hope PPHM went for the 1500$ boot because this convention is worth more then that.
icon url

biopharm

11/07/13 1:04 PM

#147670 RE: cjgaddy #147662

Thanks CJ! I have some information to read instead of my reaching to the ends of the internet to pull some speculations out : )

GLTA!
icon url

asmarterwookie

11/07/13 1:10 PM

#147671 RE: cjgaddy #147662

CJGADDY should qualify for cheap options!!

You relay more info than PPHM IR!!

Thanks for all you do Colonel!

wook
icon url

sunstar

11/07/13 1:12 PM

#147672 RE: cjgaddy #147662

"The combination of these mechanisms promotes strong localized anti-tumor responses without the side-effects of systemic immune activation."

Bavi: Immunotherapy with powerful new efficacy, but without the dangerous side effects seen in other immunotherapies.

Thanks cj.

IMO

sunstar
icon url

sunstar

11/07/13 1:31 PM

#147675 RE: cjgaddy #147662

"...significantly improved tumor free long-term survival and apparent cures in 35%…"

Peregrine's proprietary anti-PS tech is already producing cancer cures in pre-clinical. Dr. Brekken says to watch for 200%-300% increases in responses when anti-PS is used in combination with downstream immunotherapies. Those combo studies were started in June 2013, and should soon be seen in posters, and a possible phase I immunotherapy combination trial before year end. My guess is that the phase I trial would be a collaboration with a BP.

IMO

sunstar